Gene · 3276
Papers2,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TRIM21: a multifaceted regulator in cancer. | Front Cell Dev Biol | 2025 | 40735642 | PubTator, text mining | PubMed |
| Troponin I - a comprehensive review of its function, structure, evolution, and role in muscle diseases. | Anim Cells Syst (Seoul) | 2025 | 40735528 | PubTator, text mining | PubMed |
| Overexpression of Circular PRMT1 Transcripts in Colorectal Adenocarcinoma Predicts Recurrence and Poor Overall Survival. | Int J Mol Sci | 2025 | 40724932 | PubTator, text mining | PubMed |
| Targeting PRMT1-mediated methylation of TAF15 to protect against myocardial infarction by inhibiting ferroptosis via the GPX4/NRF2 pathway. | Clin Epigenetics | 2025 | 40696470 | PubTator, text mining | PubMed |
| PRMT1 oligomerization regulates RNA-binding protein cascade to promote pancreatic cancer. | Life Sci Alliance | 2025 | 40675804 | PubTator, text mining | PubMed |
| A novel 3-alkenylindol-2-one derivative selectively inhibits the growth of acute myeloid leukemia via modulation of the MYC-PRMT pathway. | Biochem Pharmacol | 2025 | 40619015 | PubTator, text mining | PubMed |
| Protein Arginine Methyltransferase 1-mediated Histone H4R3 Dimethyl Asymmetric enhances Epidermal Growth Factor Receptor signaling to promote Peritoneal Fibrosis. | Int J Biol Sci | 2025 | 40612681 | PubTator, text mining | PubMed |
| Emerging roles of protein arginine methyltransferase in multiple myeloma. | Mol Ther Oncol | 2025 | 40524859 | PubTator, text mining | PubMed |
| Hederagenin promotes SIRT6 to attenuate epidural scar formation by aggravating PRMT1 deacetylation. | Bone Joint Res | 2025 | 40511498 | PubTator, text mining | PubMed |
| PRMT1 inhibitor MS023 suppresses RNA splicing to sensitize small cell lung cancer to DNA damaging agents. | Neoplasia | 2025 | 40413955 | PubTator, text mining | PubMed |
| PRMT1 promotes immune escape in hepatocellular carcinoma by regulating arginine methylation modification of MYC protein. | Epigenetics | 2025 | 40401713 | PubTator, text mining | PubMed |
| Arginine methylation patterns in LUAD: defining prognostic subtypes and relevance to immunotherapy. | Discov Oncol | 2025 | 40399547 | PubTator, text mining | PubMed |
| PRMT1-catalyzed NUSAP1 methylation enhances Notch2 signaling and 5-FU resistance in gastric cancer. | Cell Death Dis | 2025 | 40393971 | PubTator, text mining | PubMed |
| Identification and targeting of regulators of SARS-CoV-2-host interactions in the airway epithelium. | Sci Adv | 2025 | 40378209 | PubTator, text mining | PubMed |
| Histone modifications and metabolic reprogramming in tumor-associated macrophages: a potential target of tumor immunotherapy. | Front Immunol | 2025 | 40375990 | PubTator, text mining | PubMed |
| Corrigendum to "PRMT1 methylates METTL14 to modulate its oncogenic function" [Neoplasia 42 (2023) 100912]. | Neoplasia | 2025 | 40273836 | PubTator, text mining | PubMed |
| PRMT1-Mediated SWI/SNF Complex Recruitment via SMARCC1 Drives IGF2BP2 Transcription to Enhance Carboplatin Resistance in Head and Neck Squamous Cell Carcinoma. | Adv Sci (Weinh) | 2025 | 40270464 | PubTator, text mining | PubMed |
| Identification of key hub genes associated with anti-gastric cancer effects of lotus plumule based on machine learning algorithms. | World J Gastrointest Oncol | 2025 | 40235894 | PubTator, text mining | PubMed |
| Hypoxia-induced PRMT1 methylates HIF2β to promote breast tumorigenesis via enhancing glycolytic gene transcription. | Cell Rep | 2025 | 40173041 | PubTator, text mining | PubMed |
| PRMT1-mediated modification of H4R3me2a promotes liver cancer progression by enhancing the transcriptional activity of SOX18. | Hepatol Commun | 2025 | 40130992 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3276/papers?page=7